問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Pediatrics

Division of General Internal Medicine

更新時間:2025-12-16

李妮鍾LEE, NI-CHUNG
  • Principal Investigator
  • Clinical Trial Experience (year) -13 years -3 個月

篩選

List

33Cases

2019-06-01 - 2021-08-01

Phase III

Phase 3, Open-Label, Single-Arm, Single-Dose Gene Replacement Therapy Clinical Trial for Patients with Spinal Muscular Atrophy Type 1 with One or Two SMN2 Copies Delivering AVXS-101 by Intravenous Infusion
  • Condition/Disease

    Spinal Muscular Atrophy Type 1

  • Test Drug

    AVXS-101

Participate Sites
1Sites

Recruiting1Sites

2016-03-11 - 2021-04-19

Phase II/III

A PHASE 2/3, MULTICENTER, MULTINATIONAL, OPEN-LABEL STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALXN1101 IN NEONATES WITH MOLYBDENUM COFACTOR DEFICIENCY (MOCD) TYPE A
  • Condition/Disease

    Molybdenum Cofactor Deficiency (MoCD) Type A

  • Test Drug

    ALXN1101

Participate Sites
1Sites

Terminated1Sites

2007-11-01 - 2009-11-30

Phase IV

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

1 2 3 4